Dynex Technologies, Inc.

Dynex Technologies, Inc., a for-profit manufacturer of automated ELISA processing systems and laboratory diagnostics equipment, operates as a prime contractor supplying specialized laboratory instruments, service agreements, and immunology testing reagents to federal healthcare and research agencies on a full-and-open basis, with no set-aside participation in its recent award footprint.

Dynex's core capability portfolio centers on the DSX and Agility automated ELISA processing platforms, which dominate 107 of its 156 recent awards under NAICS 334517 (Analytical Laboratory Instrument Manufacturing). The company supplies equipment, service maintenance agreements, and specialized immunology reagents to support immunoassay analysis, tuberculosis identification, and viral serology testing at federal medical facilities. Representative prime work includes a $143 thousand firm-fixed-price purchase order from Veterans Integrated Service Network 10 for a DynexA Agility Automated ELISA Processing System and accessories (awarded April 2022, sole source under FAR 13.5); a $102 thousand service agreement from Veterans Integrated Service Network 10 for DSX and Agility maintenance support through September 2026 (sole source, September 2024); and a $74 thousand DSX Electrophoresis Analyzer purchase order from the same VISN 10 facility (August 2024, sole source). The most recent award, January 2026, was a $62 thousand purchase order from Veterans Integrated Service Network 22 for DSX PM and service covering automated ELISA processing systems in Tucson, Arizona.

Customer concentration is moderate and heavily weighted to Veterans Affairs. The top five customers account for 47% of awards by count, with Veterans Integrated Service Networks 22 and 10 anchoring the VA footprint at 18 awards each ($1.1 million and $642 thousand combined potential value respectively); the Navy Bureau of Medicine and Surgery adds 16 awards ($529 thousand), the CDC 13 awards ($115 thousand), and VISN 15 nine awards ($683 thousand). The two ranking lists align closely — VISN 22 dominates both volume and dollars — reflecting Dynex's repetitive, transaction-based relationship with VA medical centers rather than large-ceiling programs or multi-agency vehicles.

Dynex places 73 task orders under the GSA Multiple Award Schedule for $2.2 million combined potential value, with smaller presence on a VA blanket purchase agreement and a General Services Administration indefinite delivery contract. The vendor operates almost entirely as a prime (100% of awards), with no subcontractor footprint in the source data. Activity has declined materially since 2021, dropping from 7 awards that year to 1 in 2026; only 3 awards with combined potential value of $205 thousand reach ultimate completion inside the next twenty-four months, indicating modest recompete exposure. Combined potential value across the 156-award portfolio stands at $10 million, with $4.2 million obligated (42% drawn). Dynex's federal contracting history with the VA, Navy, CDC, NIH, and Department of Defense extends to at least 2004, positioning the company as an established supplier of specialized laboratory automation to federal healthcare and research operations.